According to Hanmi Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 33.71%. At the end of 2022 the company had an Operating Margin of 7.35%.
Year | Operating Margin | Change |
---|---|---|
2022 | 7.35% | 37.13% |
2021 | 5.36% | 45.11% |
2020 | 3.69% | -18.85% |
2019 | 4.55% | 61.76% |
2018 | 2.81% | -46.99% |
2017 | 5.31% | 73.96% |
2016 | 3.05% | -89.98% |
2015 | 30.45% | 650.01% |
2014 | 4.06% | -24.32% |
2013 | 5.36% | -92.6% |
2012 | 72.49% | 155.82% |
2011 | 28.34% | 1968.01% |
2010 | 1.37% | -87.83% |
2009 | 11.26% | -35.97% |
2008 | 17.58% | 7.61% |
2007 | 16.34% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.